Thrive GLP-1 at $250 monthly sits between these, costing more than compounded pharmaceuticals while delivering dramatically less effectiveness
Each participant received 30 identically shaped capsules on Weeks 0, 4, 8, and 12
Most importantly, this study demonstrates that compared to SGLT2i monotherapy, combination therapy with GLP-1RA and SGLT2i is associated with better clinical outcomes in patients with MASLD
doi: 10.1038/s41591-022-01707-4 78 US National Institutes of Health
Prior authorization is common, but coverage itself is guaranteed
Considerations Mild injection-site irritation may occur Limited large-scale human data available Effects may vary depending on protocol and lifestyle Lifestyle Factors Pair with a balanced, protein-forward diet tailored to support tissue repair and recovery